Eli Lilly's new obesity drug shows promising results in weight loss, surpassing its existing drug Zepbound, as competition in ...

Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

Some patients dropped out of the trial early because they had lost so much weight.

Zealand Pharma plans to launch five obesity and related drugs by 2030 as the Danish company tries to break into the lucrative ...

Get the latest stock market and healthcare sector updates, top gainers and losers, and key regulatory news impacting investments.

In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.

Attorneys general from 21 states are suing the Trump administration over guidance that they say unlawfully blocks some legal immigrants from Supplemental Nutrition Assistance Program (SNAP) benefits.

ALTERED FUNDING ELIGIBILITY WITHOUT CONGRESSIONAL APPROVAL WHICH THEY SAY IS ILLEGAL. ## CALIFORNIA'S DEMOCRATIC LEADERS AND MEMBERS OF THE REPUBLICAN PARTY ARE PREPARING THEIR ARGUMENTS FOR AND ...

STOP TOUCHING YOUR FACE. MAJOR CHANGES COMING FOR THE WEIGHT LOSS DRUG COVERAGE IN THE NEW YEAR, AND THAT HAS PATIENTS SCRAMBLING. BUT THERE ARE SOME THINGS YOU CAN DO RIGHT NOW STARTING IN JANUARY, ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...